2017
DOI: 10.1002/eat.22707
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent persistent hypophosphatemia in a male‐to‐female transgender patient with anorexia nervosa: Case report

Abstract: Refeeding hypophosphatemia remains a serious and common complication during the early phases of nutritional rehabilitation and weight restoration for patients with anorexia nervosa. Typically, the risk of refeeding hypophosphatemia diminishes after the first 1-2 weeks of the refeeding process and thus, frequent monitoring serum phosphorus levels becomes less important as refeeding proceeds. Herein, we describe a case of persistent recurrent hypophosphatemia in a male-to-female transgender patient with severe a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 18 publications
0
6
0
Order By: Relevance
“…Most were case studies ( n = 18) detailing one to five individual cases of gender dysphoria, eating disorders, body image and dissatisfaction, and body size using a mix of qualitative and quantitative data. The findings from these case reports focused on transgender patients and their outcomes of gender affirming medical treatment [ 30 , 48 , 49 ], psychotherapy [ 50 52 ], psychiatric care [ 53 , 54 ], eating disorder treatment [ 55 59 ], nutrition assessments [ 33 ], some combination of treatments (e.g., gender affirming medical intervention and eating disorder treatment) [ 60 ], or diagnoses (e.g., autism spectrum disorder, gender dysphoria, and eating disorder) [ 61 ]. Three case reports included detailed patient medical records [ 61 , 62 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Most were case studies ( n = 18) detailing one to five individual cases of gender dysphoria, eating disorders, body image and dissatisfaction, and body size using a mix of qualitative and quantitative data. The findings from these case reports focused on transgender patients and their outcomes of gender affirming medical treatment [ 30 , 48 , 49 ], psychotherapy [ 50 52 ], psychiatric care [ 53 , 54 ], eating disorder treatment [ 55 59 ], nutrition assessments [ 33 ], some combination of treatments (e.g., gender affirming medical intervention and eating disorder treatment) [ 60 ], or diagnoses (e.g., autism spectrum disorder, gender dysphoria, and eating disorder) [ 61 ]. Three case reports included detailed patient medical records [ 61 , 62 ].…”
Section: Resultsmentioning
confidence: 99%
“…gender affirming hormone therapy, gender affirming surgery, etc.) [ 7 , 33 , 48 , 53 , 55 , 61 – 63 ], were diagnosed with gender dysphoria [ 7 , 49 , 50 , 53 , 54 , 56 58 , 60 , 61 ], had self-identified as transgender or gender non-binary/fluid [ 30 , 43 , 48 , 59 , 64 ], or some combination of these (e.g., self-identification and gender transition). One study used “biological” male or female to describe transgender participants and did not include the self-identification of the participants [ 62 ].…”
Section: Resultsmentioning
confidence: 99%
“…This sample did not represent transgender individuals who may require additional consideration in the context of hormonal treatment as seen in a recent case report of recurrent and persistent RH. 50…”
Section: Discussionmentioning
confidence: 99%
“…For patients with restrictive eating disorders already taking GAHT, it may be prudent to measure levels more frequently, given the impact of restriction on the HPA axis. In addition, one case report describes persistent hypophosphatemia past the typical duration seen in refeeding syndrome in a trans woman taking spironolactone and estrogen [ 44 ]. Further research is needed to create an evidence base for best practices of hormone treatment during eating disorder treatment.…”
Section: Hormonal Treatmentsmentioning
confidence: 99%